Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
B1207 Zileuton sodiumSummary: 5-lipoxygenase and leukotrienes inhibitor
-
A2486 MalotilateSummary: Stimulates hepatocyte regeneration
-
A5384 ZileutonSummary: 5-lipoxygenase (5-LOX) inhibitor, orally active
-
C3055 3-acetyl-11-keto-β-Boswellic AcidSummary: 5-lipoxygenase inhibitor
-
C3091 11-keto-β-Boswellic AcidSummary: leukotriene synthesis inhibitor via 5-lipoxygenase
-
C4696 Ebselen
-
C3794 1-Naphthyl 3,5-dinitrobenzoateSummary: dual 5-lipoxygenase and microsomal prostaglandin E synthase-1 inhibitor
-
C4199 HZ52Summary: 5-lipoxygenase inhibitor
-
C4371 BW 755CSummary: dual inhibitor of 5-lipoxygenase (5-LO) and cyclooxygenase (COX) pathways
-
C4828 Piriprost (potassium salt)Summary: 5-lipoxygenase inhibitor